2BB score and signals
Fennec Pharmaceuticals Inc.’s current 2BB score is 45 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 49 | Moderate |
| Momentum | 43 | Stable |
| Financial strength | 43 | Normal |
| Quality | 53 | Normal |
| Risk | 43 | Moderate |
Company facts
| Headquarters | Durham, North Carolina, United States |
| Founded | 1996 |
| Employees | 35 |
| 52-week range | $5.65 – $13.25 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-22 | — | 0.1289 | — | $21.10M |
| 2026-11-05 | — | 0.0947 | — | $19.19M |
| 2026-08-11 | 0.05 | 0.01 | $17.87M | $16.44M |
| 2026-05-14 | 0.01 | -0.0085 | $15.11M | $14.23M |
Related companies
2BBBullish & Bearish